Get started
Author

Mona Marwan Alkhawajah

Observed names: AlKhawajah, Mona, Alkhawajah, Mona, Alkhawajah, Mona Marwan, M Alkhawajah, Mona AlKhawajah, Mona Alkhawajah, Mona M Alkhawajah, Mona M. Al-Khawajah, Mona M. AlKhawajah, Mona M. Alkhawajah
ORCID: 0000-0002-6282-1977
Observed ORCID: 0000-0002-6282-1977
OpenAlex ID: A5073793343
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines
2019 · B. Yamout, M. Sahraian, et al. · Multiple Sclerosis and Related Disorders · 107
Diagnosis and treatment of progressive multiple sclerosis: A position paper
2022 · Carlo Pozzilli, Maura Pugliatti, et al. · European Journal of Neurology · 61
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
2012 · Mona M Alkhawajah, Ana B Caminero, et al. · Multiple Sclerosis Journal · 39
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
2022 · Bart Van Wijmeersch, Hans-Peter Hartung, et al. · Frontiers in Immunology · 38
PDF
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia
2021 · Mohammed Al Jumah, Ahmad Abulaban, et al. · Multiple Sclerosis and Related Disorders · 16
PDF
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
2020 · Mohamed AlJumah, Mona Marwan Alkhawajah, et al. · Neurology and Therapy · 12
PDF
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
2022 · Maura Pugliatti, Hans-Peter Hartung, et al. · Frontiers in Immunology · 11
PDF
When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?
2011 · Mona Alkhawajah, Joel Oger · Multiple Sclerosis International · 9
PDF
Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses
2022 · Yaser M. Al Malik, Ibtisam A. Al Thubaiti, et al. · Clinical and Translational Neuroscience · 6
PDF
Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists
2025 · Thomas Berger, Markus Zeitlinger, et al. · European Journal of Neurology · 5
PDF
Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Family Planning within the Management of MS
2023 · Mona M. Al-Khawajah, Rayan G. Al-Barakati, et al. · Clinical and Translational Neuroscience · 3
PDF
Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
2022 · Matthew Craner, Yaser Al Malik, et al. · Neurology and Therapy · 3
PDF
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews
2026 · Sofie Aerts, Lotte Geys, et al. · Journal of the Neurological Sciences · 2
PDF
Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Symptom Management and Vaccination
2023 · Ibtisam A. Al Thubaiti, Mona M. AlKhawajah, et al. · Clinical and Translational Neuroscience · 2
PDF
Response of Ictal Asystole to Pacemaker Implantation Documented by Video-EEG/ECG
2013 · Mona AlKhawajah, David B. MacDonald, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2
PDF
Uncovering disability progression in people with multiple sclerosis: a practical guide
2026 · Bart Van Wijmeersch, Celia Oreja-Guevara, et al. · Journal of Neurology
PDF
Neurofilament Light Chain as a Key Biomarker for Guiding Multiple Sclerosis Management: A Consensus from Asia Pacific, Middle East, and Africa
2026 · Mark Freedman, Ralf Linker, et al. · Multiple Sclerosis and Related Disorders
When Vasculitis Meets Demyelination: A Pediatric Tumefactive Central Nervous System Lesion With Overlapping Immunopathology
2026 · Abdulaziz Alasiri, Lena Alotaibi, et al. · Pediatric Neurology
Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing
2026 · Sajedi, Seyed Aidin, Zhu, Chao, et al. · Document Server@UHasselt (UHasselt)
PDF
165. Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
2024 · Matthew Craner, Yaser Al Malik, et al. · Multiple Sclerosis and Related Disorders
Real World Effectiveness of Oral Cladribine in Multiple Sclerosis Treatment, Report from a Single Saudi Center
2023 · Saeed Bohlega, Mona Alkhawajah, et al. · Multiple Sclerosis and Related Disorders
Anesthetic Management of an Obstetric Patient with Behçet’s Disease Complicated by Transverse Myelitis
2022 · Sara Alwatban, Etedal AlAamri, et al. · Case Reports in Anesthesiology
PDF
Expert opinion on clinical experience with subcutaneous interferon beta‐1a in multiple sclerosis patients with different disease activity profiles
2019 · Saeed Bohlega, Raed Alroughani, et al. · Neurology and Clinical Neuroscience
PDF
Alemtuzumab-containing reduced intensity conditioning allogenic hematopoietic stem cell transplantation in a case of primary progressive multiple sclerosis
2018 · Mohamed AlKhaja, Abdulaziz Abanmy, et al. · Multiple Sclerosis and Related Disorders
Where are we Going with Drugs to Treat MS? Will Cost Continue to Increase?
2010 · Joel Oger, Mona AlKhawajah · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
PDF
Works count: 28
Citation count: 316
H-index: 8
I10-index: 7
Year
Topic
Type